Patient burden and quality of life in atopic dermatitis in US adults: A population-based cross-sectional study

Jonathan I. Silverberg, Joel M. Gelfand, David J. Margolis, Mark Boguniewicz, Luz Fonacier, Mitchell H. Grayson, Eric Simpson, Peck Y. Ong, Zelma C. Chiesa Fuxench

Research output: Contribution to journalArticle

55 Scopus citations

Abstract

Background: The patient burden and quality of life (QOL) impact of atopic dermatitis (AD) in the United States population is not well established. Objective: To elucidate the patient burden of AD in the US population. Methods: A cross-sectional, population-based study of 602 adults was performed. Atopic dermatitis was determined using modified UK Diagnostic Criteria for AD. Its severity was assessed using self-reported global AD severity, Patient-Oriented Eczema Measure (POEM), Patient-Oriented Scoring AD (PO-SCORAD), PO-SCORAD-itch, and sleep. Quality of life was assessed using short-form (SF-)12 mental and physical health scores and Dermatology Life Quality Index (DLQI). Results: Adults with AD reported higher proportions of having only fair/poor overall health (25.8% vs. 15.8%), being somewhat/very dissatisfied with life (16.7% vs 11.4%), lower weighted mean (standard deviation [SD]) SF-12 mental (45.9 [9.9] vs 50.9 [9.2]) and physical health subscores (53.0 [2.5] vs 53.5 [2.3]) and higher DLQI (4.9 [6.5] vs 1.1 [2.8]). In multivariable regression models adjusting for sociodemographics and multiple comorbid health disorders, significant stepwise decreases by AD severity (self-reported, POEM, PO-SCORAD) of overall health, life satisfaction, SF-12 mental health, and increases of DLQI scores were seen. The SF-12 physical health scores were only associated with moderate AD. Concurrently, severe PO-SCORAD, POEM, or PO-SCORAD-itch was associated with very low mean SF-12 mental health (34.7) and high DLQI scores (24.7). Atopic dermatitis commonly limited lifestyle (51.3%), led to avoidance of social interaction (39.1%), and impacted activities (43.3%). The most burdensome AD symptoms were itch (54.4%), excessive dryness/scaling (19.6%), and red/inflamed skin (7.2%). Conclusion: These data support the heavy burden that AD places on patients, particularly those with moderate and severe AD.

Original languageEnglish (US)
Pages (from-to)340-347
Number of pages8
JournalAnnals of Allergy, Asthma and Immunology
Volume121
Issue number3
DOIs
StatePublished - Sep 1 2018

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'Patient burden and quality of life in atopic dermatitis in US adults: A population-based cross-sectional study'. Together they form a unique fingerprint.

  • Cite this

    Silverberg, J. I., Gelfand, J. M., Margolis, D. J., Boguniewicz, M., Fonacier, L., Grayson, M. H., Simpson, E., Ong, P. Y., & Chiesa Fuxench, Z. C. (2018). Patient burden and quality of life in atopic dermatitis in US adults: A population-based cross-sectional study. Annals of Allergy, Asthma and Immunology, 121(3), 340-347. https://doi.org/10.1016/j.anai.2018.07.006